Literature DB >> 4115925

Parkinson's tremor, relief by an antiaminic drug (BC 105). Discussion on the biochemical pathogenesis of Parkinsonian tremor.

A Agnoli, M Casacchia, S Ruggieri, F Volante, N Accornero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4115925     DOI： 10.1007/bf00316165

Source DB:  PubMed          Journal:  Z Neurol        ISSN： 0012-1037


× No keyword cloud information.
  5 in total

1.  [Vasoneuroactive substance, antiaminic BC-105 and migraine].

Authors:  F Sicuteri; B Anselmi; P L Del Bianco
Journal:  Clin Ter       Date:  1967-01-31

2.  Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.

Authors:  C Fazio; A Agnoli; M Casacchia; M Reitano; S Ruggieri; C Barba; F Volante
Journal:  Z Neurol       Date:  1972

3.  [Action of amantadine on parkinsonian tremor].

Authors:  A Agnoli; M Casacchia; S Ruggieri; F Volante; N Accornero
Journal:  Minerva Med       Date:  1971-10-31       Impact factor: 4.806

4.  [Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].

Authors:  G Bartholini; R Tissot
Journal:  Rev Med Liege       Date:  1970-09-15

5.  [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].

Authors:  R Tissot; J M Gaillard; M Guggisberg; G Gauthier; J de Ajuriaguerra
Journal:  Presse Med       Date:  1969-04-05       Impact factor: 1.228
  5 in total
  1 in total

1.  Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.

Authors:  C Fazio; A Agnoli; M Casacchia; M Reitano; S Ruggieri; C Barba; F Volante
Journal:  Z Neurol       Date:  1972
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.